Selected Publications

1.

Zhang, L. et al. RAS pathway targeted therapy in patients with DICER1-associated sarcomas. npj Precision Oncology 9, 232 (2025).

2.

Tiburcio, P. D. B. et al. PD-L1 expression is mediated by microRNA processing, wnt/β-catenin signaling, and chemotherapy in wilms tumor. Pediatric Blood & Cancer 72, e31852 (2025).

3.

Tiburcio, P. D. B., Chen, K., Xu, L. & Chen, K. S. Suppressing proteasome activity enhances sensitivity to actinomycin d in diffuse anaplastic wilms tumor. Cell Reports Medicine 6, (2025).

4.

Fraire, C. R. et al. An imbalance between proliferation and differentiation underlies the development of microRNA-defective pineoblastoma. Genes & Development 39, 727–750 (2025).

5.

Schoettler, P. J. et al. Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the international pleuropulmonary blastoma/DICER1 registry. Pediatric Blood & Cancer 71, e31090 (2024).

6.

Tiburcio, P. D. B. et al. DROSHA regulates mesenchymal gene expression in wilms tumor. Molecular Cancer Research 22, 711–720 (2024).

7.

Fraire, C. R. et al. Intronic germline DICER1 variants in patients with sertoli–leydig cell tumor. JCO Precision Oncology 7, e2300189 (2023).

8.

Aguayo, J. S. et al. Ectopic PLAG1 induces muscular dystrophy in the mouse. Biochemical and Biophysical Research Communications 665, 159–168 (2023).